FDA Inspection 1216981 — Nexira Inc.
The FDA completed an inspection of Nexira Inc. on August 30, 2023 in Somerville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 30, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Somerville, NJ (United States)
Additional Details
FSVP